Published in Br J Radiol on November 16, 2010
X-ray-computed tomography contrast agents. Chem Rev (2012) 1.52
Multifunctional gold nanoparticles for diagnosis and therapy of disease. Mol Pharm (2013) 1.48
Targeted gold nanoparticles enable molecular CT imaging of cancer: an in vivo study. Int J Nanomedicine (2011) 1.40
Gold nanoparticle imaging and radiotherapy of brain tumors in mice. Nanomedicine (Lond) (2012) 1.30
pHLIP peptide targets nanogold particles to tumors. Proc Natl Acad Sci U S A (2012) 1.19
Intravenous magnetic nanoparticle cancer hyperthermia. Int J Nanomedicine (2013) 1.07
Dual-energy micro-CT functional imaging of primary lung cancer in mice using gold and iodine nanoparticle contrast agents: a validation study. PLoS One (2014) 1.06
Roadmap to Clinical Use of Gold Nanoparticles for Radiation Sensitization. Int J Radiat Oncol Biol Phys (2015) 0.96
Targeted nanotechnology for cancer imaging. Adv Drug Deliv Rev (2014) 0.91
Order of magnitude sensitivity increase in X-ray Fluorescence Computed Tomography (XFCT) imaging with an optimized spectro-spatial detector configuration: theory and simulation. IEEE Trans Med Imaging (2014) 0.89
Gold nanoparticles in radiation research: potential applications for imaging and radiosensitization. Transl Cancer Res (2013) 0.88
Degradable polymer-coated gold nanoparticles for co-delivery of DNA and siRNA. Acta Biomater (2014) 0.88
Computed tomography imaging-guided radiotherapy by targeting upconversion nanocubes with significant imaging and radiosensitization enhancements. Sci Rep (2013) 0.86
In vivo X-ray computed tomographic imaging of soft tissue with native, intravenous, or oral contrast. Sensors (Basel) (2013) 0.85
Personalized nanomedicine advancements for stem cell tracking. Adv Drug Deliv Rev (2012) 0.84
Towards real-time detection of tumor margins using photothermal imaging of immune-targeted gold nanoparticles. Int J Nanomedicine (2012) 0.84
Bisphosphonate-functionalized gold nanoparticles for contrast-enhanced X-ray detection of breast microcalcifications. Biomaterials (2013) 0.82
Gold nanoparticle hyperthermia reduces radiotherapy dose. Nanomedicine (2014) 0.81
A computational framework for identifying design guidelines to increase the penetration of targeted nanoparticles into tumors. Nano Today (2013) 0.80
Structure-activity relationships for biodistribution, pharmacokinetics, and excretion of atomically precise nanoclusters in a murine model. Nanoscale (2013) 0.79
Enhanced cytotoxic activity of cetuximab in EGFR-positive lung cancer by conjugating with gold nanoparticles. Sci Rep (2014) 0.79
A multifunctional nanoplatform for imaging, radiotherapy, and the prediction of therapeutic response. Small (2014) 0.79
Gum arabic-coated radioactive gold nanoparticles cause no short-term local or systemic toxicity in the clinically relevant canine model of prostate cancer. Int J Nanomedicine (2014) 0.79
Nanotechnology in dentistry: prevention, diagnosis, and therapy. Int J Nanomedicine (2015) 0.78
Second Generation Gold Nanobeacons for Robust K-Edge Imaging with Multi-Energy CT. J Mater Chem (2012) 0.78
Size dependent translocation and fetal accumulation of gold nanoparticles from maternal blood in the rat. Part Fibre Toxicol (2014) 0.78
Enhancement of radiation effect on cancer cells by gold-pHLIP. Proc Natl Acad Sci U S A (2015) 0.77
Evaluation of uptake and distribution of gold nanoparticles in solid tumors. Eur Phys J Plus (2015) 0.76
An image guided small animal stereotactic radiotherapy system. Oncotarget (2016) 0.75
Engineering iodine-doped carbon dots as dual-modal probes for fluorescence and X-ray CT imaging. Int J Nanomedicine (2015) 0.75
Optimizing conditions for labeling of mesenchymal stromal cells (MSCs) with gold nanoparticles: a prerequisite for in vivo tracking of MSCs. J Nanobiotechnology (2017) 0.75
A 3D in vitro cancer model as a platform for nanoparticle uptake and imaging investigations. Small (2014) 0.75
Vascular targeting of nanoparticles for molecular imaging of diseased endothelium. Adv Drug Deliv Rev (2016) 0.75
Gold nanoparticles allow detection of early-stage edema in mice via computed tomography imaging. Int J Nanomedicine (2015) 0.75
In vivo small animal micro-CT using nanoparticle contrast agents. Front Pharmacol (2015) 0.75
Synthesis and characterization of pHLIP(®) coated gold nanoparticles. Biochem Biophys Rep (2017) 0.75
In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nat Biotechnol (2007) 7.33
Gold nanoparticles: a new X-ray contrast agent. Br J Radiol (2006) 6.31
Direct visualization of the binding and internalization of a ferritin conjugate of epidermal growth factor in human carcinoma cells A-431. J Cell Biol (1979) 5.62
Near-infrared resonant nanoshells for combined optical imaging and photothermal cancer therapy. Nano Lett (2007) 4.82
Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Res (2006) 4.43
The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol (2004) 4.43
Nanotechnology applications in cancer. Annu Rev Biomed Eng (2007) 3.88
Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer Res (2009) 3.77
PEG-modified gold nanorods with a stealth character for in vivo applications. J Control Release (2006) 3.74
Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv (2004) 3.65
High resolution X-ray computed tomography: an emerging tool for small animal cancer research. Neoplasia (2000) 3.22
Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am J Pathol (1988) 3.06
Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf B Biointerfaces (2008) 2.78
Targeted gold nanoparticles enable molecular CT imaging of cancer. Nano Lett (2008) 2.55
Adsorbents for affinity chromatography. Use of N-hydroxysuccinimide esters of agarose. Biochemistry (1972) 2.55
Selective probing and imaging of cells with single walled carbon nanotubes as near-infrared fluorescent molecules. Nano Lett (2008) 2.51
Radiotherapy enhancement with gold nanoparticles. J Pharm Pharmacol (2008) 2.15
Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. Biomaterials (2009) 2.13
Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J Pharm Sci (2001) 2.09
Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging. Clin Cancer Res (2008) 1.96
Colloidal gold nanoparticles as a blood-pool contrast agent for X-ray computed tomography in mice. Invest Radiol (2007) 1.92
Estimation of tumour dose enhancement due to gold nanoparticles during typical radiation treatments: a preliminary Monte Carlo study. Phys Med Biol (2005) 1.91
Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells. Oncogene (1994) 1.88
Early phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissues. Jpn J Cancer Res (1998) 1.68
In vivo molecular imaging to diagnose and subtype tumors through receptor-targeted optically labeled monoclonal antibodies. Neoplasia (2007) 1.65
Small-animal PET imaging of human epidermal growth factor receptor type 2 expression with site-specific 18F-labeled protein scaffold molecules. J Nucl Med (2008) 1.63
Radiotherapy in the presence of contrast agents: a general figure of merit and its application to gold nanoparticles. Phys Med Biol (2008) 1.49
A phase I trial of humanized monoclonal antibody A33 in patients with colorectal carcinoma: biodistribution, pharmacokinetics, and quantitative tumor uptake. Clin Cancer Res (2005) 1.36
Dual-energy CT iodine-subtraction virtual unenhanced technique to detect urinary stones in an iodine-filled collecting system: a phantom study. AJR Am J Roentgenol (2008) 1.35
Neuroprotective effects of estradiol in middle-aged female rats. Endocrinology (2001) 1.28
Imaging of HER2/neu-positive BT-474 human breast cancer xenografts in athymic mice using (111)In-trastuzumab (Herceptin) Fab fragments. Nucl Med Biol (2005) 1.28
Circulation and distribution of gold nanoparticles and induced alterations of tissue morphology at intravenous particle delivery. J Biophotonics (2009) 1.17
PAMAM dendrimer-based contrast agents for MR imaging of Her-2/neu receptors by a three-step pretargeting approach. Magn Reson Med (2008) 1.13
In vivo evaluation of 177Lu- and 67/64Cu-labeled recombinant fragments of antibody chCE7 for radioimmunotherapy and PET imaging of L1-CAM-positive tumors. Clin Cancer Res (2005) 1.08
Novel bimodal bifunctional ligands for radioimmunotherapy and targeted MRI. Bioconjug Chem (2008) 1.01
In vivo single molecular imaging and sentinel node navigation by nanotechnology for molecular targeting drug-delivery systems and tailor-made medicine. Breast Cancer (2008) 0.99
Renal cyst pseudoenhancement at multidetector CT: what are the effects of number of detectors and peak tube voltage? Radiology (2008) 0.99
Preoperative imaging of colorectal carcinoma with 111In-labeled anticarcinoembryonic antigen monoclonal antibody. Cancer Res (1986) 0.99
Ligand density effect on biorecognition by PEGylated gold nanoparticles: regulated interaction of RCA120 lectin with lactose installed to the distal end of tethered PEG strands on gold surface. Biomacromolecules (2005) 0.93
Effects of estradiol and progesterone on plasma gonadotropins, prolactin, and LHRH in specific brain areas of ovariectomized rats. Biol Reprod (1981) 0.91
HER-2-mediated endocytosis of magnetic nanospheres and the implications in cell targeting and particle magnetization. Biomaterials (2008) 0.90
Correlative Instrumental Neutron Activation Analysis, Light Microscopy, Transmission Electron Microscopy, and X-ray Microanalysis for Qualitative and Quantitative Detection of Colloidal Gold Spheres in Biological Specimens. Microsc Microanal (1998) 0.90
Synthesis and evaluation of near-infrared (NIR) dye-herceptin conjugates as photoacoustic computed tomography (PCT) probes for HER2 expression in breast cancer. Bioconjug Chem (2008) 0.89
Comparison of in vitro cell binding characteristics of four monoclonal antibodies and their individual tumor localization properties in mice. Cancer Res (1990) 0.82
Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma. Cancer Biother Radiopharm (2001) 0.80
Gold nanoparticles: a new X-ray contrast agent. Br J Radiol (2006) 6.31
The permeability of the endplate channel to organic cations in frog muscle. J Gen Physiol (1980) 5.00
The permeability of endplate channels to monovalent and divalent metal cations. J Gen Physiol (1980) 4.72
Seizure control and mortality in epilepsy. Ann Neurol (1999) 3.28
Tensile properties of the human femur-anterior cruciate ligament-tibia complex. The effects of specimen age and orientation. Am J Sports Med (1991) 2.64
Calcium release and reabsorption in the sartorius muscle of the toad. Biochem Biophys Res Commun (1966) 2.60
Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur. Neuroscience (2002) 2.57
Ionic currents in molluscan soma. Annu Rev Neurosci (1980) 2.57
Prospects for microbeam radiation therapy of brain tumours in children to reduce neurological sequelae. Dev Med Child Neurol (2007) 2.29
Characteristics of sodium and calcium conductance changes produced by membrane depolarization in an Aplysia neurone. J Physiol (1979) 2.06
Block of endplate channels by permeant cations in frog skeletal muscle. J Gen Physiol (1981) 2.00
The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300. J Virol (1999) 1.94
Psychiatric aspects of temporal lobe epilepsy before and after anterior temporal lobectomy. J Neurol Neurosurg Psychiatry (2000) 1.94
Atypical pulmonary thrombosis caused by a toxic cyanobacterial peptide. Science (1983) 1.86
Calcium entry through receptor-operated channels in bovine pulmonary artery endothelial cells. Tissue Cell (1987) 1.74
Calcium supplementation with and without hormone replacement therapy to prevent postmenopausal bone loss. Ann Intern Med (1994) 1.68
Brevetoxin-3 (PbTx-3) and its derivatives modulate single tetrodotoxin-sensitive sodium channels in rat sensory neurons. J Pharmacol Exp Ther (1998) 1.63
Comparison of depth and subdural electrodes in recording temporal lobe seizures. Neurology (1989) 1.61
Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates. J Virol (1999) 1.60
Calcium-activated potassium channels in native endothelial cells from rabbit aorta: conductance, Ca2+ sensitivity and block. J Physiol (1992) 1.49
Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patient. Int J Cancer (1987) 1.47
The activating mutation R201C in GNAS promotes intestinal tumourigenesis in Apc(Min/+) mice through activation of Wnt and ERK1/2 MAPK pathways. Oncogene (2010) 1.45
Association between variation in the human KCNJ10 potassium ion channel gene and seizure susceptibility. Epilepsy Res (2004) 1.42
Adenosine triphosphate-evoked currents in cultured neurones dissociated from rat parasympathetic cardiac ganglia. J Physiol (1991) 1.41
The RASSF1A isoform of RASSF1 promotes microtubule stability and suppresses tumorigenesis. Mol Cell Biol (2005) 1.40
Acute bacterial cholangitis: an analysis of clinical manifestation. Arch Surg (1982) 1.38
Microbeam radiation therapy. Med Phys (1993) 1.38
Neuropathology of ablation of rat gliosarcomas and contiguous brain tissues using a microplanar beam of synchrotron-wiggler-generated X rays. Int J Cancer (1998) 1.37
Acetylcholine-evoked currents in cultured neurones dissociated from rat parasympathetic cardiac ganglia. J Physiol (1991) 1.35
Gating currents associated with sodium and calcium currents in an Aplysia neuron. Science (1976) 1.35
Ionic currents in response to membrane depolarization in an Aplysia neurone. J Physiol (1979) 1.34
The relationship of brevetoxin 'length' and A-ring functionality to binding and activity in neuronal sodium channels. Chem Biol (1995) 1.28
Interaction of azole antifungal antibiotics with cytochrome P-450-dependent 14 alpha-sterol demethylase purified from Candida albicans. Biochem J (1990) 1.27
muO-conotoxin MrVIB selectively blocks Nav1.8 sensory neuron specific sodium channels and chronic pain behavior without motor deficits. Proc Natl Acad Sci U S A (2006) 1.26
Subacute neuropathological effects of microplanar beams of x-rays from a synchrotron wiggler. Proc Natl Acad Sci U S A (1995) 1.26
Feasibility of noninvasive analysis of lead in the human tibia by soft x-ray fluorescence. Med Phys (1983) 1.25
The effect of human herpesvirus-6 (HHV-6) on cultured human neural cells: oligodendrocytes and microglia. J Neurovirol (1998) 1.23
Synchronized oscillations in cytoplasmic free calcium concentration in confluent bradykinin-stimulated bovine pulmonary artery endothelial cell monolayers. J Biol Chem (1989) 1.23
Novel omega-conotoxins from Conus catus discriminate among neuronal calcium channel subtypes. J Biol Chem (2000) 1.23
Membrane potential and Na(+)-K+ pump activity modulate resting and bradykinin-stimulated changes in cytosolic free calcium in cultured endothelial cells from bovine atria. J Biol Chem (1990) 1.23
Sodium and calcium gating currents in an Aplysia neurone. J Physiol (1979) 1.22
Interaction of internal anions with potassium channels of the squid giant axon. J Gen Physiol (1983) 1.22
Estrogen induced synthesis of specific proteins in human breast cancer cells. Biochem Biophys Res Commun (1980) 1.22
Nuclear matrix attachment regions of human papillomavirus type 16 repress or activate the E6 promoter, depending on the physical state of the viral DNA. J Virol (2000) 1.17
Two new classes of conopeptides inhibit the alpha1-adrenoceptor and noradrenaline transporter. Nat Neurosci (2001) 1.17
The identification of Candida albicans strains by restriction fragment length polymorphism analysis of DNA. J Med Vet Mycol (1989) 1.17
Estrogen regulation of specific messinger RNA's in human breast cancer cells. Biochem Biophys Res Commun (1980) 1.16
Attenuation of signaling pathways stimulated by pathologically activated FGF-receptor 2 mutants prevents craniosynostosis. Proc Natl Acad Sci U S A (2006) 1.15
The Oxford hip and knee outcome questionnaires for arthroplasty. J Bone Joint Surg Br (2005) 1.14
Chemical and elemental analysis of humans in vivo using improved body composition models. Am J Physiol (1991) 1.14
Inhibitors of calcium buffering depress evoked transmitter release at the squid giant synapse. J Physiol (1985) 1.13
Cytochrome P-450-dependent 14 alpha-demethylation of lanosterol in Candida albicans. Biochem J (1989) 1.13
Distribution of an estrogen-induced protein with a molecular weight of 24,000 in normal and malignant human tissues and cells. Cancer Res (1983) 1.13
Monovalent and divalent cation permeability and block of neuronal nicotinic receptor channels in rat parasympathetic ganglia. J Gen Physiol (1995) 1.12
Auras and subclinical seizures: characteristics and prognostic significance. Ann Neurol (1990) 1.12
Language before and after temporal lobectomy: specificity of acute changes and relation to early risk factors. Epilepsia (1995) 1.10
Synergy of gene-mediated immunoprophylaxis and microbeam radiation therapy for advanced intracerebral rat 9L gliosarcomas. J Neurooncol (2006) 1.10
A noninvasive protocol for anterior temporal lobectomy. Neurology (1992) 1.10
A new, sensitive polynucleotide probe for distinguishing Candida albicans strains and its use with a computer assisted archiving and pattern comparison system. J Med Vet Mycol (1992) 1.09
Voltage sensitivity of inhibitory postsynaptic current in Aplysia buccal ganglia. Brain Res (1976) 1.09
Inhibitory postsynaptic currents at Aplysia cholinergic synapses: effects of permeant anions and depressant drugs. Proc R Soc Lond B Biol Sci (1982) 1.08
The effects of knee motion and external loading on the length of the anterior cruciate ligament (ACL): a kinematic study. J Biomech Eng (1991) 1.07
Expression of the Staphylococcus aureus UDP-N-acetylmuramoyl- L-alanyl-D-glutamate:L-lysine ligase in Escherichia coli and effects on peptidoglycan biosynthesis and cell growth. J Bacteriol (1999) 1.07
Are alpha9alpha10 nicotinic acetylcholine receptors a pain target for alpha-conotoxins? Mol Pharmacol (2007) 1.06
Analysis of the frequency of GNAS codon 201 mutations in advanced colorectal cancer. Cancer Genet Cytogenet (2010) 1.05
Memory deficits before and after temporal lobectomy: effect of laterality and age of onset. Brain Cogn (1989) 1.05
Mania following temporal lobectomy. Neurology (2003) 1.05
Passive and active membrane properties of isolated rat intracardiac neurons: regulation by H- and M-currents. J Neurophysiol (1997) 1.04
Single amino acid substitutions in alpha-conotoxin PnIA shift selectivity for subtypes of the mammalian neuronal nicotinic acetylcholine receptor. J Biol Chem (1999) 1.04
Purification and properties of cytochrome P-450-dependent 14 alpha-sterol demethylase from Candida albicans. Biochem J (1989) 1.04
Identification of human cytochromes P-450 analogous to forms induced by phenobarbital and 3-methylcholanthrene in the rat. Biochem J (1985) 1.03
Sex hormones and fungi. Adv Microb Physiol (1993) 1.03
A 1-y walking program and increased dietary calcium in postmenopausal women: effects on bone. Am J Clin Nutr (1991) 1.03
Heterogeneity of nicotinic receptor class and subunit mRNA expression among individual parasympathetic neurons from rat intracardiac ganglia. J Neurosci (1997) 1.03
Resting membrane potential and potassium currents in cultured parasympathetic neurones from rat intracardiac ganglia. J Physiol (1992) 1.03
Localization of subclinical ictal activity by functional magnetic resonance imaging: correlation with invasive monitoring. Ann Neurol (1995) 1.02
Calcium entry-dependent oscillations of cytoplasmic calcium concentration in cultured endothelial cell monolayers. Proc Natl Acad Sci U S A (1992) 1.02
L-line x-ray fluorescence of cortical bone lead compared with the CaNa2EDTA test in lead-toxic children: public health implications. Proc Natl Acad Sci U S A (1989) 1.01
Bradykinin and inositol 1,4,5-trisphosphate-stimulated calcium release from intracellular stores in cultured bovine endothelial cells. Pflugers Arch (1989) 1.01
Divalent ion currents and the delayed potassium conductance in an Aplysia neurone. J Physiol (1980) 1.01
Correlating lamotrigine serum concentrations with tolerability in patients with epilepsy. Neurology (2004) 1.01
Impaired proliferation and tumorigenicity induced by CCAAT/enhancer-binding protein. Cancer Res (1996) 1.01
Monoclonal antibody storage conditions, and concentration effects on immunohistochemical specificity. J Histochem Cytochem (1983) 1.01
Neurotransmission in neonatal rat cardiac ganglion in situ. Am J Physiol (1990) 1.00
Detection of a Mr 24,000 estrogen-regulated protein in human breast cancer by monoclonal antibodies. Cancer Res (1983) 1.00
In vivo measurement of cortical bone lead using polarized x rays. Med Phys (1989) 0.99
Comparison of mesial versus neocortical onset temporal lobe seizures: neurodiagnostic findings and surgical outcome. Epilepsia (1995) 0.99
Radiosurgical palliation of aggressive murine SCCVII squamous cell carcinomas using synchrotron-generated X-ray microbeams. Br J Radiol (2006) 0.99
Large-conductance calcium-activated potassium channels in neonatal rat intracardiac ganglion neurons. Pflugers Arch (2001) 0.99
MRI evidence of impaired CSF homeostasis in obesity-associated idiopathic intracranial hypertension. AJNR Am J Neuroradiol (2012) 0.98
X-ray microbeams: Tumor therapy and central nervous system research. Nucl Instrum Methods Phys Res A (2005) 0.98
Hippocampal cell density and subcortical metabolism in temporal lobe epilepsy. Epilepsia (1999) 0.98
Sequential measurements of bone lead content by L X-ray fluorescence in CaNa2EDTA-treated lead-toxic children. Environ Health Perspect (1991) 0.98
Expression and function of neuronal nicotinic ACh receptors in rat microvascular endothelial cells. Am J Physiol Heart Circ Physiol (2003) 0.97
Ionic selectivity of native ATP-activated (P2X) receptor channels in dissociated neurones from rat parasympathetic ganglia. J Physiol (2001) 0.97
Induction of drug metabolizing enzymes in human liver cell line Hep G2. FEBS Lett (1985) 0.97
Neurosurgical treatment of medically intractable status epilepticus. Epilepsy Res (2001) 0.96